CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
31.65 0.11(0.35%) NAV as on 29 Apr 2026
3.6 % 1 M
5.82 % 1 Y
22.83 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.30

As on 31 Mar, 2026
age-icon Age :

6 yrs 9 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

858.87 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.43

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2026
Others 2.35 %
Equity 97.65 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.42 %
Apollo Hospitals Enterprise Ltd.7.34 %
Torrent Pharmaceuticals Ltd.5.03 %
JB Chemicals & Pharmaceuticals...4.99 %
Aurobindo Pharma Ltd.4.42 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs77.97
Hospital & Healthcare Services18.05
Business Support0.90
Chemicals0.73
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)18.2216.3626.4529.3930.19
Net Assets(Rs Crores) (as on 31-Mar-2026) 515.33 428.44 699.55 814.95 858.87
Scheme Returns(%)(Absolute)12.40-10.2661.3810.034.21
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7570/7611/9032/10220/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity31.650.11(0.35%)NAV As on 29 Apr, 202610-Jul-2019Inception Date858.87AUM In Cr.5.82%1Y22.83%3Y12.77%5Y18.44%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity39.81-0.08(-0.20%)NAV As on 29 Apr, 202613-Jul-2018Inception Date6,293.14AUM In Cr.6.82%1Y26.87%3Y16.30%5Y19.38%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity436.91-1.19(-0.27%)NAV As on 29 Apr, 202614-Jul-1999Inception Date4,063.64AUM In Cr.3.42%1Y24.66%3Y15.72%5Y15.84%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity40.220.07(0.18%)NAV As on 29 Apr, 202602-Jul-2018Inception Date2,753.72AUM In Cr.9.68%1Y23.91%3Y14.64%5Y19.45%Since Inception
Nippon India Pharma Fund(G)Very HighEquity517.351.50(0.29%)NAV As on 29 Apr, 202605-Jun-2004Inception Date7,898.24AUM In Cr.4.18%1Y22.15%3Y13.63%5Y19.73%Since Inception